Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Prism Medico and Pharmacy Ltd. operates in a competitive finance investment sector, where its financial metrics indicate significant underperformance compared to its peers. Companies like Authum Investment & Infrastructure Ltd. and Bajaj Finserv Ltd. stand out for their robust profitability and growth, while Prism’s negative PE and low revenue growth highlight its struggles. Therefore, it is crucial to consider the strengths of the sector leaders while assessing investment strategies.
Highest ROE (33.88%) and low debt-equity ratio (0.0718), indicating strong profitability and low financial risk.
Strong revenue growth (21.23% YoY) and robust profitability metrics (ROE of 29.52%) make it a standout performer.